Boundless Bio

Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.

Overview Structured Data Issues Contributors

boundlessbio.com

Is a

Company attributes

Industry

Synthetic chemistry

Precision Oncology

0

Location

B2X

0

Legal Name

Boundless Bio, Inc.

Number of Employees (Ranges)

51 – 2000

Full Address

11099 N Torrey Pines Rd, Suite 280, La Jolla, California 92037, US0

Investors

PFM Health Sciences

ARCH Venture Partners

Vertex Ventures

City Hill Ventures

GT Healthcare Capital Partners

Vertex Ventures HC

...

Total Funding Amount (USD)

250,085,007

249,500,000

Latest Funding Round Date

May 2021

April 28, 2021

Latest Funding Type

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

105,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Boundless Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.